Health

‘Three-parent IVF’ was supposed to prevent mitochondrial disease. Studies are raising doubts

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 03/11/2026, 09:36:24 UTC.

Briefings

Recent U.K. data revealed eight healthy children born via mitochondrial replacement techniques (MRT) to mothers carrying mitochondrial disease mutations, suggesting the procedure can prevent fatal conditions. However, emerging data from U.K. studies and small international pilot clinics are raising concerns about the risks and benefits of using MRT as a first treatment for mitochondrial disease. The evidence supports the potential of MRT but highlights significant uncertainty regarding its safety and efficacy in clinical settings.

Key points

• Eight healthy children were born to mothers carrying mitochondrial disease mutations using mitochondrial replacement techniques (MRT) in the U.K. last year.
• Emerging data from U.K. studies and small international pilot clinics are raising questions about whether MRT is the best first use for mitochondrial disease.

Context

Mitochondrial replacement techniques (MRT) combine genes from a mother and father with mutation-free DNA in the mitochondria of a donor egg. The U.K. announcement of eight healthy children showed the promise of MRT in preventing mitochondrial disease, raising hopes for other countries like the U.S. where MRT is banned. Australia, the second country to explicitly legalize MRT, is preparing to launch a national experiment.

Limitations

Evidence is limited to a single U.K. study and several small international pilot studies. No additional background on MRT risks or benefits is supplied. The findings are preliminary and subject to further research.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 03/11/2026, 10:35:01 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeigofxlviqxpsc5puiybge6rqnb3qfr62oljaxol2ktgdsadig5nui